Adlai Nortye Ltd.
Adlai Nortye Ltd. (ANL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
anl · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Adlai Nortye Ltd. (ANL) measures how much investors pay for each dollar of the company's trailing earnings. ANL's current PE ratio of N/A is calculated by dividing its stock price of $9.71 by its TTM earnings per share of -$3.33.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Adlai Nortye Ltd.You ANL | $515M | N/A | — | -$3.33 |
 Adaptimmune Therapeutics plc ADAP | $75M | N/A | — | -$0.28 |
 Aditxt, Inc. ADTX | $0M | N/A | — | -$1116.70 |
 Ainos, Inc. AIMD | $10M | N/A | — | -$3.46 |
 Apollomics, Inc. APLM | $16M | N/A | — | -$7.57 |
 BioLineRx Ltd. BLRX | $14M | N/A | — | -$0.29 |
 GeoVax Labs, Inc. GOVX | $1M | N/A | — | -$22.40 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-3.33 | — | |
2024-12-31 FY2024 | — | $-4.87 | — | |
2023-12-31 FY2023 | — | $-16.05 | — | |
2022-12-31 FY2022 | — | $-6.93 | — | |
2021-12-31 FY2021 | — | $-6.68 | — | |
2020-12-31 FY2020 | — | $-7.47 | — | |
2019-12-31 FY2019 | — | $-2.10 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Adlai Nortye Ltd. (ANL) measures how much investors pay for each dollar of the company's trailing earnings. ANL's current PE ratio of N/A is calculated by dividing its stock price of $9.71 by its TTM earnings per share of -$3.33.
Frequently asked questions
ANL pe ratio · 6 questionsANL's current PE ratio is N/A as of 2026-06-08, based on a stock price of $9.71 and TTM EPS of -$3.33. Data sourced from Financial Modeling Prep via ANL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Adlai Nortye Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08